The inability of the nation's fragmented health IT systems to communicate with one another has made the task of leveraging data extremely difficult, as have concerns about patient privacy and protecting personal health information.
The Health IT (HITECH) portion of the 2009 American Recovery and Reinvestment Act (ARRA) authorized $20 billion to promote EHR adoption, as well as regional interconnectivity and expand the Office of the National Coordinator for Health Information Technology (ONC), headed now by David Blumenthal of Harvard Medical School.
HITECH strengthens privacy and disclosure requirements for e-health systems as a way to bolster public trust in EHR programs, while provisions expect doctors and hospitals to demonstrate that they are making "meaningful use" of certified EHR systems in order to qualify for Medicare bonus payments. That means providing patients access to their health records, implementing computerized order systems, and using IT to submit insurance claims and track patients' medications and lab results.
HITECH supports these efforts by providing $2 billion to help providers adopt qualifying technology; by assisting states and communities in establishing health information exchanges; by developing interoperability standards; and by examining a range of technical and policy issues that impede HIT implementation.
All these efforts support a National Health Information Network that ideally will provide more data on healthcare costs, quality and outcomes. EHRs will accomplish little, says Blumenthal, unless health data "can flow freely, privately and securely to the places where they are needed."
SAFER DRUG USE
Increased connectivity among healthcare entities also promises to support more timely monitoring and oversight of medical products by FDA. Congress has instructed FDA to establish a Sentinel System able to detect signals of adverse events for medical products by accessing health records on 100 million people by July 2012.
To meet this goal, FDA is starting with a "mini" Sentinel system that utilizes a distributed data model to tap into medical records held by large health plans and insurers, including CIGNA, Kaiser Permanente and the HMO Research Network. A second phase next year will access additional data from Medicare and other government health programs.
The Harvard Pilgrim Health Care system recently signed a $72 million contract with FDA to coordinate operations for Sentinel and ensure data quality. The distributed data model has the health system data source evaluate its information and transmit summaries to Sentinel, making it unnecessary for FDA to build its own large database, which would raise privacy issues.
While Sentinel's purpose is to serve FDA's regulatory mission, the long-term vision is that it will be part of a larger IT system that also provides data for outcomes studies, comparative effectiveness research and health system quality reporting. And this, in turn, provides additional incentives for providers to participate in e-health activities.
Jill Wechsler, a veteran reporter, has been covering Capitol Hill since 1994.
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
Talking PIE, the Act, Before Thanksgiving
November 23rd 2022AMCP CEO Susan A. Cantrell spoke with Managed Healthcare Executive® about Preapproval Information Exchange (PIE) Act of 2022, which would allow drug manufacturers to share information about a drug with payers before the drug is approved. Cantrell says passage of the PIE Act would speed up patient access to new medications.
Read More
Inflation Reduction Act and the Impact on Pharmaceutical Pricing and Investment Decisions
November 21st 2022The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Read More